» Authors » Zoe Michael

Zoe Michael

Explore the profile of Zoe Michael including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 160
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Michael Z, Brewer N
Law Hum Behav . 2024 Sep; PMID: 39325383
Objective: Defense attorneys sometimes suggest that social-cognitive difficulties render autistic individuals vulnerable to involvement in crime, often arguing that theory of mind (ToM) difficulties that undermine inferences about others' intentions...
2.
Adams E, Deivasigamani S, Kotamarti S, Wolf S, Mottaghi M, Aminsharifi A, et al.
Prostate . 2024 Jun; 84(13):1224-1233. PMID: 38926139
Purpose: To compare the efficacy of a novel fusion template "reduced six-core systemic template and multiparametric magnetic resonance imaging/transrectal ultrasound (mpMRI/TRUS) fusion targeted biopsy" (TBx+6c), with mpMRI/TRUS fusion-targeted biopsy and...
3.
Deivasigamani S, Adams E, Kotamarti S, Mottaghi M, Taha T, Aminsharifi A, et al.
Prostate Cancer Prostatic Dis . 2023 Nov; 27(2):294-299. PMID: 38001362
Background: Prostate cancer (PCa) diagnosis relies on biopsies, with transrectal ultrasound (TRUS) biopsies being common. Fusion biopsy (FB) offers improved diagnostic accuracy, but the pain and anxiety experienced by patients...
4.
Deivasigamani S, Kotamarti S, Rastinehad A, Salas R, de la Rosette J, Lepor H, et al.
Eur Urol . 2023 Jul; 84(6):547-560. PMID: 37419773
Context: Whole-gland ablation is a feasible and effective minimally invasive treatment for localized prostate cancer (PCa). Previous systematic reviews supported evidence for favorable functional outcomes, but oncological outcomes were inconclusive...
5.
Deivasigamani S, Kotamarti S, Adams E, Seguier D, Zhang D, Michael Z, et al.
Eur J Radiol . 2023 Jun; 165:110929. PMID: 37352682
Purpose: PI-RADS 4 lesions are considered to have a "high" likelihood of clinically-significant prostate cancer (csPCa). However, patients undergoing targeted biopsy have a range of histologic findings. Understanding discordant cases...
6.
Tan W, Kotamarti S, Ayala A, Mahle R, Chen E, Arcot R, et al.
Eur Urol Oncol . 2023 Mar; 6(3):289-294. PMID: 36890104
Background: There is no consensus on the optimal approach for salvage local therapy in radiation-resistant/recurrent prostate cancer (RRPC). Objective: To investigate oncological and functional outcomes for men treated with salvage...
7.
Kosmas K, Michael Z, Papathanasiou A, Spyropoulos F, Adib E, Jasuja R, et al.
Int J Mol Sci . 2022 Sep; 23(18). PMID: 36142826
Pulmonary arterial hypertension (PAH) is a serious, progressive, and often fatal disease that is in urgent need of improved therapies that treat it. One of the remaining therapeutic challenges is...
8.
Tan W, Kotamarti S, Chen E, Mahle R, Arcot R, Chang A, et al.
Cancer . 2022 Sep; 128(21):3824-3830. PMID: 36107496
Background: This study reports the oncological and functional outcomes in men with localized prostate cancer (Pca) who were treated with primary whole gland cryoablation (WGC) of the prostate. Methods: The...
9.
Kotamarti S, Gupta R, Wang B, Seguier D, Michael Z, Zhang D, et al.
Eur Urol Oncol . 2022 Jul; 5(5):483-493. PMID: 35879190
There is uncertainty with how to proceed when targeted prostate biopsy of suspicious multiparametric magnetic resonance imaging (mpMRI) lesions return without clinically significant prostate cancer (csPCa). While possible, there are...
10.
Kotamarti S, Michael Z, Silver D, Teper E, Aminsharifi A, Polascik T, et al.
Urol Oncol . 2022 Apr; 40(5):199.e9-199.e14. PMID: 35379535
Introduction And Objectives: Cryoablation offers a treatment option for small renal masses ideally suited ≤3 cm. In well-selected candidates, it is associated with less perioperative morbidity compared to more invasive...